Regeneron's blockbuster eye drug posts weaker sales due to inventory impact Reuters.com - 02 May 2024 Regeneron's blockbuster eye drug posts weaker sales due to inventory impact ... More
Regeneron reveals potential delay for Dupixent in COPD, stagnant sales for Eylea FiercePharma - 02 May 2024 Regeneron reveals potential delay for Dupixent in COPD, stagnant sales for Eylea ... More
Decoding Regeneron Pharmaceuticals Inc (REGN): A Strategic SWOT Insight Yahoo Finance - 03 May 2024 Decoding Regeneron Pharmaceuticals Inc (REGN): A Strategic SWOT Insight ... More
Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day MarketWatch - 02 May 2024 Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day ... More
Regeneron Reverses On Better-Than-Feared Eylea Sales Investor's Business Daily - 02 May 2024 Regeneron Reverses On Better-Than-Feared Eylea Sales ... More
Regeneron Pharmaceuticals Targets Quality Weight Loss In Latest Obesity Innovation Investing.com UK - 02 May 2024 Regeneron Pharmaceuticals Targets Quality Weight Loss In Latest Obesity Innovation ... More
Regeneron, Lilly grapple with clinical endpoints as obesity space moves to improving weight loss Fierce Biotech - 02 May 2024 Regeneron, Lilly grapple with clinical endpoints as obesity space moves to improving weight loss ... More
Regeneron misses profit estimates on weaker Eylea and Dupixent sales ETHealthWorld - 02 May 2024 Regeneron misses profit estimates on weaker Eylea and Dupixent sales ... More
Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings: Challenges and Opportunities Amidst ... Yahoo Finance - 02 May 2024 Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings: Challenges and Opportunities Amidst ... ... More
Industry Comparison: Evaluating Regeneron Pharmaceuticals Against Competitors In Biotechnology Industry By ... Investing.com UK - 02 May 2024 Industry Comparison: Evaluating Regeneron Pharmaceuticals Against Competitors In Biotechnology Industry By ... ... More
Is Weakness In Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock A Sign That The Market Could be Wrong ... Yahoo Finance UK - 02 May 2024 Is Weakness In Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock A Sign That The Market Could be Wrong ... ... More
Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 20 Years Investing.com UK - 02 May 2024 Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 20 Years ... More
Regeneron Pharmaceuticals 1Q Revenue Declines Amid Lower EYLEA Sales MarketWatch - 02 May 2024 Regeneron Pharmaceuticals 1Q Revenue Declines Amid Lower EYLEA Sales ... More
Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales Yahoo Finance - 02 May 2024 Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales ... More
Regeneron’s stock rallies as pipeline prospects outweigh earnings miss MarketWatch - 02 May 2024 Regeneron’s stock rallies as pipeline prospects outweigh earnings miss ... More
Regeneron’s stock dips premarket after earnings fall short of estimates MarketWatch - 02 May 2024 Regeneron’s stock dips premarket after earnings fall short of estimates ... More
Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day MarketWatch - 01 May 2024 Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day ... More
Regeneron's stock jumps 4% as analysts look to pipeline MarketWatch - 02 May 2024 Regeneron's stock jumps 4% as analysts look to pipeline ... More
Regeneron Pharmaceuticals Inc. stock outperforms competitors despite losses on the day MarketWatch - 30 Apr 2024 Regeneron Pharmaceuticals Inc. stock outperforms competitors despite losses on the day ... More